Cagrilintide dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (160 mcg @ 75 kg). Educational only, never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 100–135 mcg | 0.10–0.14 mL | 4–5 units0.04–0.05 mL | – |
| 60–75 kg / 132–165 lb | 122–166 mcg | 0.12–0.17 mL | 5–7 units0.05–0.07 mL | – |
| 75–90 kg / 165–198 lb | 150–202 mcg | 0.15–0.20 mL | 6–8 units0.06–0.08 mL | – |
| 90–105 kg / 198–231 lb | 177–239 mcg | 0.18–0.24 mL | 7–10 units0.07–0.10 mL | – |
| >105 kg / >231 lb | 204–276 mcg | 0.20–0.28 mL | 8–11 units0.08–0.11 mL | – |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. No published half-life on file for Cagrilintide; the elapsed-time column is hidden.
Cagrilintide by goal
Read Cagrilintide's profile and dosing through a specific research-goal lens.
Dose & PK references
Selected from the Cagrilintide bibliography for relevance to dosing and pharmacokinetics.
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.